Literature DB >> 12482722

Intrinsic nerve circuits of the gastrointestinal tract: identification of drug targets.

John B Furness1, Gareth J Sanger.   

Abstract

Advances in understanding the pathophysiological role of neurotransmitters and neurotransmitter receptors that are expressed by neurons of the intrinsic circuits of the intestine will aid the selection of new drug targets for therapeutic compounds. The major components of the intrinsic circuits for motility, secretion and blood flow control in the small and large intestines have been identified in recent years, although the intrinsic circuits in the stomach are still not adequately determined. In the guinea-pig small intestine, where circuits have been most accurately defined, there are 14 functionally identified neuron types, each with a characterised pharmacology of transmission.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12482722     DOI: 10.1016/s1471-4892(02)00219-9

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  10 in total

1.  Cross-inhibition between nicotinic acetylcholine receptors and P2X receptors in myenteric neurons and HEK-293 cells.

Authors:  Dima A Decker; James J Galligan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-02       Impact factor: 4.052

2.  Purinergic receptors and synaptic transmission in enteric neurons.

Authors:  Jianhua Ren; Paul P Bertrand
Journal:  Purinergic Signal       Date:  2007-12-08       Impact factor: 3.765

Review 3.  Laxative abuse: epidemiology, diagnosis and management.

Authors:  James L Roerig; Kristine J Steffen; James E Mitchell; Christie Zunker
Journal:  Drugs       Date:  2010-08-20       Impact factor: 9.546

4.  Mediation of neurogenic ion transport by acetylcholine, prostanoids and 5-hydroxytryptamine in porcine ileum.

Authors:  DeWayne Townsend; Melissa A Casey; David R Brown
Journal:  Eur J Pharmacol       Date:  2005-09-20       Impact factor: 4.432

5.  Bioengineered in vitro enteric nervous system.

Authors:  Eleana Manousiouthakis; Ying Chen; Dana M Cairns; Rachel Pollard; Kaia Gerlovin; Michael J Dente; Yasmin Razavi; David L Kaplan
Journal:  J Tissue Eng Regen Med       Date:  2019-07-22       Impact factor: 3.963

Review 6.  Colonic smooth muscle cells and colonic motility patterns as a target for irritable bowel syndrome therapy: mechanisms of action of otilonium bromide.

Authors:  Jakub Rychter; Francisco Espín; Diana Gallego; Patri Vergara; Marcel Jiménez; Pere Clavé
Journal:  Therap Adv Gastroenterol       Date:  2014-07       Impact factor: 4.409

Review 7.  Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.

Authors:  Alessandro Lecci; Angela Capriati; Carlo Alberto Maggi
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

8.  A randomised double-blind placebo-controlled phase II study of AGI004 for control of chemotherapy-induced diarrhoea.

Authors:  V M Coyle; D Lungulescu; C Toganel; A Niculescu; S Pop; T Ciuleanu; C Cebotaru; J Devane; M Martin; R H Wilson
Journal:  Br J Cancer       Date:  2013-03-05       Impact factor: 7.640

9.  Specific localization of β-Arrestin2 in myenteric plexus of mouse gastrointestinal tract.

Authors:  Hercules T Maguma; Dipanjana Datta De; Sukhada Bhave; William L Dewey; Hamid I Akbarali
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

10.  Neurochemical characterization of myenteric neurons in the juvenile gilthead sea bream (Sparus aurata) intestine.

Authors:  Chiara Ceccotti; Cristina Giaroni; Michela Bistoletti; Manuela Viola; Francesca Crema; Genciana Terova
Journal:  PLoS One       Date:  2018-08-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.